Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.

Panayiotis G. Vlachoyiannopoulos, Sophie Toya, G E Katsifis, Athanasios G. Tzioufas, Haralampos Μ. Moutsopoulos

PubMed · 2008 · 13 citations · 0 references

Abstract

Our data suggest that CYC therapy might be associated with upregulation of aPL and development of antiphospholipid syndrome despite suppression of SLE activity.